期刊文献+

高密度脂蛋白心血管保护作用新进展:功能及机制 被引量:12

Progress of cardioprotective effects of high density lipoprotein:function and mechanism
下载PDF
导出
摘要 高密度脂蛋白是一种脂质和蛋白含量大致均等的异质性脂蛋白,可分为多种亚类。高密度脂蛋白通过促进胆固醇逆转运,抑制低密度脂蛋白氧化修饰,抑制血管炎症,抑制血栓形成,促进内皮修复,抗细胞凋亡等发挥抗动脉粥样硬化的作用已经成为共识。最近研究发现了高密度脂蛋白发挥心血管保护作用的新机制,主要为抑制免疫炎症反应,抑制造血干细胞增殖,调节血糖代谢等,对高密度脂蛋白及其亚类在心血管保护方面的作用有了进一步的认识。本文总结高密度脂蛋白心血管保护的新功能以及HDL亚类与这些功能之间的关系。 The high density lipoprotein(HDL) in human plasma is a heterogeneous lipoprotein consisting of roughly equal contents of lipid and protein in roughly equal content,and it consists of several subtypes.HDL possesses several well-documented functions,including anti-atherosclerosis by promoting reverse cholesterol transport,inhibiting the oxidative modification of low density lipoproteins(LDLs),inhibiting vascular inflammation,preventing thrombosis and apoptosis,and promoting endothelial repair.Recently,more cardiovascular protective functions of HDL have been found,mainly including the ability of suppressing immune inflammatory reaction,inhibiting the proliferation of hematopoietic stem cells,and regulating the plasma glucose level.It is of great importance to understand how different HDL subtypes contribute to the potentially cardioprotective functions.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2014年第11期908-911,共4页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金(81370380) 广东省产学研项目(2012B091100155) 广东省科技计划项目(2011B031800065)~~
关键词 脂蛋白类 HDL 动脉粥样硬化 免疫 炎症 造血干细胞 lipoprotein HDL atherosclerosis immunity inflammation hematopoietic stem cells
  • 相关文献

参考文献30

二级参考文献36

  • 1李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1782
  • 2Konig A,Klauss V. Virtual histology[J]. Heart,2007,93(8):977.
  • 3Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the A- merican College of Cardiology task force on clinical expert consensus documents developed in collaboration with the european society of cardiology endorsed by the society of cardiac angiography and interven-tions[J]. J Am Coll Cardiol, 2001, 37(5):1478.
  • 4Sanidas EA, Maehara A, Mintz GS, et al. Angioscopy and virtual histology intravascular ultrasound characteristics of culprit lesion morphology underlying coronary artery throm-bosis[J]. Ame J Cardiol,2011,107(9) :1285.
  • 5Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications[ J ]. Circulation, 2001,103 ( 4 ) :604.
  • 6Nasu K, Tsuchikane E, Katoh O, et al. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology [J]. J Am Coll Cardiol, 2006,47 ( 12 ) :2405.
  • 7Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study [ J ]. Am Heart J, 1985,110(5) :1100.
  • 8Noike H, Hitsumoto T, Sakurai T, et al. Relationship between intravascular ultrasonographic findings and coronary risk factors in patients with normal coronary angiography [J]. J Cardiol,2005,45(1) :1.
  • 9Kimura T, Itoh T, Fusazaki T, et al. Low-density lipoprotein-cholesterol/high-density lipoprotein-eholesterol ratio predicts lipid-rich coronary plaque in patients with coronary artery disease[J]. Cire J,2010,74(7) :1392.
  • 10Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta analysis of prospective studies[J]. Cir culation, 2000,102 ( 10 ) : 1082.

共引文献39

同被引文献87

引证文献12

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部